Abstract
Objective
The aim of this study was to evaluate the serum levels of lipids in patients with normal weight (NW) or obesity with or without chronic periodontitis (ChP).
Materials and methods
One hundred and sixty non-smoking patients without history of diabetes and/or cardiovascular events were allocated into one of the following groups: NW patients with periodontal health (NWH; n = 40), NW patients with ChP (NWChP; n = 40), obese patients with periodontal health (ObH; n = 40), and obese patients with ChP (ObChP; n = 40). Serum levels of total cholesterol (TC), low-density lipoprotein (LDL), high-density lipoprotein (HDL), and triglycerides (TRG) were estimated.
Results
After adjustments for gender and age, both NW groups presented lower levels of TRG than both obese groups (p < 0.05). The NWH group presented lower levels of LDL than both periodontitis groups (p < 0.05) and the lowest TC/HDL ratio when compared to the other groups (p < 0.05). Females from the NWH group exhibited higher levels of HDL and lower LDL/HDL ratio than females from the ObChP group (p < 0.05). Furthermore, individuals from the ObChP group were more likely to have levels of LDL ≥130 mg/dl and HDL ≤40 mg/dl, compared to those from the NWH group (p < 0.05).
Conclusions
ChP and obesity, jointly or individually, are associated with undesirable pro-atherogenic lipid profiles.
Clinical relevance
There is interest in identifying clinical conditions associated with dyslipidemia to improve preventive and treatment strategies. This study demonstrated that ChP, obesity, and the association of both conditions might be related to pro-atherogenic lipid profiles.
Similar content being viewed by others
References
Bosomworth NJ (2013) Approach to identifying and managing atherogenic dyslipidemia: a metabolic consequence of obesity and diabetes. Can Fam Physician 59:1169–1180
Lösche W, Karapetow F, Pohl A, Pohl C, Kocher T (2000) Plasma lipid and blood glucose levels in patients with destructive periodontal disease. J Clin Periodontol 27:537–541
Katz J, Flugelman MY, Goldberg A, Heft M (2002) Association between periodontal pockets and elevated cholesterol and low density lipoprotein cholesterol levels. J Periodontol 73:494–500
Monteiro AM, Jardini MA, Alves S, Giampaoli V, Aubin EC, Figueiredo Neto AM, Gidlund M (2009) Cardiovascular disease parameters in periodontitis. J Periodontol 80:378–388
Ramirez-Tortosa MC, Quiles JL, Battino M, Granados S, Morillo JM, Bompadre S, Newman HN, Bullon P (2010) Periodontitis is associated with altered plasma fatty acids and cardiovascular risk markers. Nutr Metab Cardiovasc Dis 20:133–139
López-Jornet P, Berná-Mestre JD, Berná-Serna JD, Camacho-Alonso F, Fernandez-Millan S, Reus-Pintado M (2012) Measurement of atherosclerosis markers in patients with periodontitis: a case-control study. J Periodontol 83:690–698
Andrukhov O, Haririan H, Bertl K, Rausch WD, Bantleon HP, Moritz A, Rausch-Fan X (2013) Nitric oxide production, systemic inflammation and lipid metabolism in periodontitis patients: possible gender aspect. J Clin Periodontol 40:916–923
Kumar KR, Ranganath V, Naik R, Banu S, Nichani AS (2014) Assessment of high-sensitivity C-reactive protein and lipid levels in healthy adults and patients with coronary artery disease, with and without periodontitis—a cross-sectional study. J Periodontal Res 49:836–844
Sandi RM, Pol KG, Basavaraj P, Khuller N, Singh S (2014) Association of serum cholesterol, triglyceride, high and low density lipoprotein (HDL and LDL) levels in chronic periodontitis subjects with risk for cardiovascular disease (CVD): a cross sectional study. J Clin Diagn Res 8:214–216
Shah R, Thomas R, Mehta DS (2014) Oxidized-low density lipoprotein in gingival crevicular fluid of patients with chronic periodontitis: a possible link to atherogenesis. Acta Odontol Scand 72:154–156
Banu S, Jabir NR, Mohan R, Manjunath NC, Kamal MA, Kumar KR, Zaidi SK, Khan MS, Tabrez S (2015) Correlation of Toll-like receptor 4, interleukin-18, transaminases, and uric acid in patients with chronic periodontitis and healthy adults. J Periodontol 86:431–439
Liu J, Wu Y, Ding Y, Meng S, Ge S, Deng H (2010) Evaluation of serum levels of C-reactive protein and lipid profiles in patients with chronic periodontitis and/or coronary heart disease in an ethnic Han population. Quintessence Int 41:239–247
Saxlin T, Suominen-Taipale L, Kattainen A, Marniemi J, Knuuttila M, Ylöstalo P (2008) Association between serum lipid levels and periodontal infection. J Clin Periodontol 35:1040–1047
Korhonen S, Saxlin T, Suominen L, Jula A, Knuuttila M, Ylöstalo P (2011) Serum cholesterol ratios and periodontal infection: results of the Health 2000 Survey. J Clin Periodontol 38:787–794
Altay U, Gürgan CA, Ağbaht K (2013) Changes in inflammatory and metabolic parameters after periodontal treatment in patients with and without obesity. J Periodontol 84:13–23
Pires JR, Dos Santos IP, de Camargo LF, Zuza EP, de Toledo BE, Monteiro SC (2014) Framingham cardiovascular risk in patients with obesity and periodontitis. J Indian Soc Periodontol 18:14–18
World Health Organization. Waist circumference and waist–hip ratio: report of a WHO expert consultation: Geneva, 2008, December: 1–47.
Armitage GC (1999) Development of a classification system for periodontal diseases and conditions. Ann Periodontol 4:1–6
Araujo MW, Hovey KM, Benedek JR, Grossi SG, Dorn J, Wactawski-Wende J, Genco RJ, Trevisan M (2003) Reproducibility of probing depth measurement using a constant-force electronic probe: analysis of inter- and intraexaminer variability. J Periodontol 74:1736–1740
Söder B, Airila Månsson S, Söder PO, Kari K, Meurman J (2006) Levels of matrix metalloproteinases-8 and -9 with simultaneous presence of periodontal pathogens in gingival crevicular fluid as well as matrix metalloproteinase-9 and cholesterol in blood. J Periodontal Res 41:411–417
Penumarthy S, Penmetsa GS, Mannem S (2013) Assessment of serum levels of triglycerides, total cholesterol, high-density lipoprotein cholesterol, and low-density lipoprotein cholesterol in periodontitis patients. J Indian Soc Periodontol 17:30–35
Miyazawa H, Honda T, Miyauchi S, Domon H, Okui T, Nakajima T, Tabeta K, Yamazaki K (2012) Increased serum PCSK9 concentrations are associated with periodontal infection but do not correlate with LDL cholesterol concentration. Clin Chim Acta 413:154–159
Lee JB, Yi HY, Bae KH (2013) The association between periodontitis and dyslipidemia based on the Fourth Korea National Health and Nutrition Examination Survey. J Clin Periodontol 40:437–442
Ardila CM, Olarte-Sossa M, Ariza-Garcés AA (2015) Association between the presence of Treponema denticola and reduced levels of antiatherogenic high density lipoprotein in periodontitis. Quintessence Int 46:207–215
Castro AV, Kolka CM, Kim SP, Bergman RN (2014) Obesity, insulin resistance and comorbidities? Mechanisms of association. Arq Bras Endocrinol Metabol 58:600–609
Martin-Rodriguez E, Guillen-Grima F, Martí A, Brugos-Larumbe A (2015) Comorbidity associated with obesity in a large population: the APNA study. Obes Res Clin Pract 15:00057–00055
Bush TL, Fried LP, Barrett-Connor E (1988) Cholesterol, lipoproteins, and coronary heart disease in women. Clin Chem 34:B60–B70
Goh VH, Tong TY, Mok HP, Said B (2007) Differential impact of aging and gender on lipid and lipoprotein profiles in a cohort of healthy Chinese Singaporeans. Asian J Androl 9:787–794
Liu HH, Li JJ (2015) Aging and dyslipidemia: a review of potential mechanisms. Ageing Res Rev 19:43–52
Wilson PW (2004) Assessing coronary heart disease risk with traditional and novel risk factors. Clin Cardiol 27(6 Suppl 3):III7–II11
Cole CB, Nikpay M, McPherson R (2015) Gene-environment interaction in dyslipidemia. Curr Opin Lipidol 26:133–138
Natarajan S, Glick H, Criqui M, Horowitz D, Lipsitz SR, Kinosian B (2003) Cholesterol measures to identify and treat individuals at risk for coronary heart disease. Am J Prev Med 25:50–57
Takahashi O, Glasziou PP, Perera R, Shimbo T, Fukui T (2010) Lipid re-screening: what is the best measure and interval? Heart 96:448–452
Khovidhunkit W, Kim MS, Memon RA, Shigenaga JK, Moser AH, Feingold KR, Grunfeld C (2004) Effects of infection and inflammation on lipid and lipoprotein metabolism: mechanisms and consequences to the host. J Lipid Res 45:1169–1196
Norata GD, Pirillo A, Ammirati E, Catapano AL (2012) Emerging role of high density lipoproteins as a player in the immune system. Atherosclerosis 220:11–21
Soran H, Hama S, Yadav R, Durrington PN (2012) HDL functionality. Curr Opin Lipidol 23:353–366
Pirillo A, Catapano AL, Norata GD (2015) HDL in infectious diseases and sepsis. Handb Exp Pharmacol 224:483–508
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Funding
The work was partially supported by the São Paulo State Research Foundation (São Paulo, São Paulo, Brazil; #2010/01930-3).
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. This study protocol was previously approved by Guarulhos University’s Ethics Committee in Clinical Research (SISNEP 417-33/2009).
Informed consent
Informed consent was obtained from all individual participants included in the study.
Rights and permissions
About this article
Cite this article
Cury, E.Z., Santos, V.R., Maciel, S.d.S. et al. Lipid parameters in obese and normal weight patients with or without chronic periodontitis. Clin Oral Invest 22, 161–167 (2018). https://doi.org/10.1007/s00784-017-2095-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00784-017-2095-1